Clinical trials
Phase 2 Hepatitis C trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
15 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 2 |
| 2008 | 1 |
| 2009 | 3 |
| 2010 | 6 |
| 2011 | 1 |
| 2018 | 1 |
| 2019 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 5 |
| Debiopharm International SA | 2 |
| Tibotec Pharmaceuticals, Ireland | 2 |
| Astellas Pharma Inc | 1 |
| Bristol-Myers Squibb | 1 |
| Human Genome Sciences Inc. | 1 |
| Merck Sharp & Dohme LLC | 1 |
| Santaris Pharma A/S | 1 |
| ZymoGenetics | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 15 |
| Hepatitis C, Chronic | 4 |
| Chronic Pain | 1 |
| Hepatitis | 1 |
| Infections | 1 |
| Liver Diseases | 1 |
| Virus Diseases | 1 |
Trials
Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.